Qingsong Liu
Affiliations: | Chinese Academic Science, High Magnetic Field Laboratory |
Area:
Translation medicineGoogle:
"Qingsong Liu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang C, Zou F, Qi Z, et al. (2024) Discovery of Pyrazolo[1,5-]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors. Journal of Medicinal Chemistry |
Zhou B, Wang B, Zou F, et al. (2023) Discovery of dihydropyridinone derivative as a covalent EZH2 degrader. European Journal of Medicinal Chemistry. 261: 115825 |
Hu C, Shen L, Zou F, et al. (2023) Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy. Acta Pharmaceutica Sinica. B. 13: 3694-3707 |
Liang X, Deng M, Zou F, et al. (2023) Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor. European Journal of Medicinal Chemistry. 260: 115768 |
Liang Q, Wang B, Zou F, et al. (2023) Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor. European Journal of Medicinal Chemistry. 256: 115411 |
Wang A, Liu J, Li X, et al. (2023) Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment. European Journal of Pharmacology. 175752 |
Guo C, Zhang L, Zhao M, et al. (2023) Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytotherapy Research : Ptr |
Mei H, Wu H, Yang J, et al. (2023) Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduction and Targeted Therapy. 8: 18 |
Wang ZW, Zou FM, Wang AL, et al. (2022) Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1. Acta Pharmacologica Sinica |
Liang X, Wang C, Wang B, et al. (2022) Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors. European Journal of Medicinal Chemistry. 243: 114782 |